We are live on
!
Find out more
Amphastar Pharmaceuticals
AMPH
AMPH
134 hedge funds and large institutions have $418M invested in Amphastar Pharmaceuticals in 2016 Q3 according to their latest regulatory filings, with 40 funds opening new positions, 60 increasing their positions, 22 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
300% more first-time investments, than exits
New positions opened: 40 | Existing positions closed: 10
173% more repeat investments, than reductions
Existing positions increased: 60 | Existing positions reduced: 22
60% more capital invested
Capital invested by funds: $261M → $418M (+$157M)
29% more funds holding
Funds holding: 104 → 134 (+30)
21% less call options, than puts
Call options by funds: $355K | Put options by funds: $448K
Holders
134
Holders Change
+30
Holders Change %
+28.85%
% of All Funds
3.58%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
40
Increased
60
Reduced
22
Closed
10
Calls
$355K
Puts
$448K
Net Calls
-$93K
Net Calls Change
-$784K
Top Buyers
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$6.73M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$2.71M |
| 3 |
UBS AM
Chicago,
Illinois
|
-$1.03M |
| 4 |
EI
EAM Investors
Solana Beach,
California
|
-$970K |
| 5 |
Fisher Asset Management
Camas,
Washington
|
-$956K |
